Bildkälla: Stockfoto

Acarix Q3 2023: Softer sales but lower costs than estimated - Redeye

Redeye comments on Acarix's Q3 report which came in short of our estimates in terms of sales but due to lower costs loss was lower than expected on the EBIT level.

Redeye comments on Acarix's Q3 report which came in short of our estimates in terms of sales but due to lower costs loss was lower than expected on the EBIT level.
Börsvärldens nyhetsbrev
ANNONSER